Dahlke MH - Search Results

1

Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy.

Obermajer N, Popp FC, Soeder Y, Haarer J, Geissler EK, Schlitt HJ, Dahlke MH. Obermajer N, et al. Among authors: dahlke mh. J Immunol. 2014 Nov 15;193(10):4988-99. doi: 10.4049/jimmunol.1401776. Epub 2014 Oct 10. J Immunol. 2014. PMID: 25305313

2

Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model.

Inoue S, Popp FC, Koehl GE, Piso P, Schlitt HJ, Geissler EK, Dahlke MH. Inoue S, et al. Among authors: dahlke mh. Transplantation. 2006 Jun 15;81(11):1589-95. doi: 10.1097/01.tp.0000209919.90630.7b. Transplantation. 2006. PMID: 16770249

3

Mesenchymal stem cells can affect solid organ allograft survival.

Popp FC, Eggenhofer E, Renner P, Geissler EK, Piso P, Schlitt HJ, Dahlke MH. Popp FC, et al. Among authors: dahlke mh. Transplantation. 2009 May 15;87(9 Suppl):S57-62. doi: 10.1097/TP.0b013e3181a288aa. Transplantation. 2009. PMID: 19424009 Review.

4

Mesenchymal stem cells as immunomodulators after liver transplantation.

Popp FC, Renner P, Eggenhofer E, Slowik P, Geissler EK, Piso P, Schlitt HJ, Dahlke MH. Popp FC, et al. Among authors: dahlke mh. Liver Transpl. 2009 Oct;15(10):1192-8. doi: 10.1002/lt.21862. Liver Transpl. 2009. PMID: 19790154 Free article. Review.

5

Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model.

Eggenhofer E, Renner P, Soeder Y, Popp FC, Hoogduijn MJ, Geissler EK, Schlitt HJ, Dahlke MH. Eggenhofer E, et al. Among authors: dahlke mh. Transpl Immunol. 2011 Sep;25(2-3):141-7. doi: 10.1016/j.trim.2011.06.002. Epub 2011 Jun 17. Transpl Immunol. 2011. PMID: 21704160

6

Heart grafts tolerized through third-party multipotent adult progenitor cells can be retransplanted to secondary hosts with no immunosuppression.

Eggenhofer E, Popp FC, Mendicino M, Silber P, Van't Hof W, Renner P, Hoogduijn MJ, Pinxteren J, van Rooijen N, Geissler EK, Deans R, Schlitt HJ, Dahlke MH. Eggenhofer E, et al. Among authors: dahlke mh. Stem Cells Transl Med. 2013 Aug;2(8):595-606. doi: 10.5966/sctm.2012-0166. Epub 2013 Jul 8. Stem Cells Transl Med. 2013. PMID: 23836805 Free PMC article.

7

Double deficiency for RORγt and T-bet drives Th2-mediated allograft rejection in mice.

Sabet-Baktach M, Eggenhofer E, Rovira J, Renner P, Lantow M, Farkas SA, Malaisé M, Edtinger K, Shaotang Z, Koehl GE, Dahlke MH, Schlitt HJ, Geissler EK, Kroemer A. Sabet-Baktach M, et al. Among authors: dahlke mh. J Immunol. 2013 Oct 15;191(8):4440-6. doi: 10.4049/jimmunol.1301741. Epub 2013 Sep 20. J Immunol. 2013. PMID: 24058178

8

Rationale and prospects of mesenchymal stem cell therapy for liver transplantation.

Obermajer N, Popp FC, Johnson CL, Benseler V, Dahlke MH. Obermajer N, et al. Among authors: dahlke mh. Curr Opin Organ Transplant. 2014 Feb;19(1):60-4. doi: 10.1097/MOT.0000000000000031. Curr Opin Organ Transplant. 2014. PMID: 24231429 Review.

9

Caveats of mesenchymal stem cell therapy in solid organ transplantation.

Haarer J, Johnson CL, Soeder Y, Dahlke MH. Haarer J, et al. Among authors: dahlke mh. Transpl Int. 2015 Jan;28(1):1-9. doi: 10.1111/tri.12415. Epub 2014 Sep 30. Transpl Int. 2015. PMID: 25082213 Free article. Review.

10

Mesenchymal stromal cells for immunoregulation after liver transplantation: the scene in 2016.

Johnson CL, Soeder Y, Dahlke MH. Johnson CL, et al. Among authors: dahlke mh. Curr Opin Organ Transplant. 2016 Dec;21(6):541-549. doi: 10.1097/MOT.0000000000000361. Curr Opin Organ Transplant. 2016. PMID: 27750256 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters